Do you exercise regularly? Are you between 18-35 years old? If so, you may be eligible to participate in a research study examining how the brain, eyes, and heart work together to maintain balance. Compensation provided.

Are you experiencing symptoms of menopause? Have you noticed a change in your mood during your menopausal transition? If you have missed at least two periods, you may be able to take part in a research study. In this study, we want to learn how mood and stress may affect risk for heart disease in women during menopause.

Do you suffer from migraines? Are you interested in helping with migraine research?

Have you previously been screened for lung cancer? Or are you currently scheduled for a lung cancer screening? We are looking for Black/African American men and women between the ages of 50-80 to participate in a study about lung cancer. Compensation is provided.

Do you have a blood cancer or have received a stem cell transplant and have been diagnosed with a respiratory infection? If so, you might be eligible to take part in a study to see if an experimental treatment is effective at reducing the severity of the respiratory infection.

Are you a stroke survivor living with arm or hand weakness? Join our research study to help us learn how your brain talks to your muscles. This study involves just one visit with safe, non-invasive brain stimulation and easy movement tasks. Your help could make a big difference in stroke recovery research.

We are enrolling participants in a research study focused on a new treatments for food allergy. If you or your child have a diagnosed egg, milk or peanut allegry, you may be eligible to take part. This is a unique opportunity to help advance care and contribute to future therapies. Participation is voluntary, and all study-related care is provided at no cost. Contact us to learn more.

Do you have Acute Myeloid Leukemia (AML) and want to try a new study drug that might help treat your cancer?

Have you been diagnosed with GCB Subtype of Diffuse LargeB-cell Lymphoma (DLBCL)? If so, you may be able to take part in a research study looking at Evaluating the Efficacy and Safety of Zilovertamab Vedotin (MK-2140) Plus R-CHP Versus Polatuzumab Vedotin Plus R-CHP in Treatment-naïve Participants With GCB Subtype of Diffuse Large B-cell Lymphoma (DLBCL

Do you feel that your reaction time has slowed after your ACL injury? Has your ability to make decisions on the field/gym/court been impacted? If so, you may be eligible for a study examining the effect a quick joint manipulation has on your reaction time and decision making abilities after your ACL injury.